Century Therapeutics (IPSC) Assets (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Assets of $326.6 million for Q1 2026, up 3.47% year-over-year from $315.6 million in Q1 2025, and up 45.98% quarter-over-quarter from $223.7 million in Q4 2025.
Century Therapeutics (IPSC) Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Assets for 7 consecutive years, with $326.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 3.47% year-over-year to $326.6 million; the TTM figure through Mar 2026 stood at $326.6 million (up 3.47% YoY), while the FY2025 annual figure was $223.7 million, down 36.67% from the prior year.
- Assets grew to $326.6 million in Q1 2026 per IPSC's latest filing, from $223.7 million in the prior quarter.
- Across five years, Assets topped out at $550.3 million in Q1 2022 and bottomed at $223.7 million in Q4 2025.
- Historically, Assets has averaged $389.1 million across 5 years, with a median of $388.6 million in 2024.
- Annual changes were most pronounced in 2022 — Assets increased 11.24% — and 2025, when it sank 37.03%.
- Century Therapeutics' Assets stood at $486.5 million in 2022, then fell by 25.87% to $360.7 million in 2023, then retreated by 2.07% to $353.2 million in 2024, then slumped by 36.67% to $223.7 million in 2025, then jumped by 45.98% to $326.6 million in 2026.
- Business Quant data shows IPSC's Assets at $326.6 million in Q1 2026, $223.7 million in Q4 2025, and $244.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 287.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 287.01 Mn |
| Mar 31, 2026 | 326.55 Mn |
| Dec 31, 2025 | 223.70 Mn |
| Sep 30, 2025 | 244.72 Mn |
| Jun 30, 2025 | 284.69 Mn |
| Mar 31, 2025 | 315.61 Mn |
| Dec 31, 2024 | 353.22 Mn |
| Sep 30, 2024 | 388.62 Mn |
| Jun 30, 2024 | 416.45 Mn |
| Mar 31, 2024 | 348.51 Mn |
| Dec 31, 2023 | 360.69 Mn |
| Sep 30, 2023 | 397.55 Mn |
| Jun 30, 2023 | 417.16 Mn |
| Mar 31, 2023 | 456.23 Mn |
| Dec 31, 2022 | 486.54 Mn |
| Sep 30, 2022 | 511.75 Mn |
| Jun 30, 2022 | 532.58 Mn |
| Mar 31, 2022 | 550.31 Mn |
| Dec 31, 2021 | 437.38 Mn |
| Sep 30, 2021 | 469.73 Mn |